The Harvard Drug Group LLC recalls

All The Harvard Drug Group LLC recalls we track from FDA, CPSC and NHTSA data. Categories: drugs (8).

8 recalls published between July 9, 2025 and July 1, 2026. Most common issues: potency (1).

• Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg… recall
  FDA July 1, 2026 · The Harvard Drug Group LLC · Class II
• Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram… recall
  FDA April 29, 2026 · The Harvard Drug Group LLC · Class II
• Memantine Hydrochloride Extended-Release, Capsules, 7 mg… recall
  FDA April 22, 2026 · The Harvard Drug Group LLC · Class II
• Midodrine Hydrochloride Tablets, USP, 5 mg… recall
  FDA March 11, 2026 · The Harvard Drug Group LLC · Class II
• Gabapentin Capsules, USP, 100 mg, 10 Capsules (10 x 1 blister pack)… recall
  FDA October 29, 2025 · The Harvard Drug Group LLC · Class II
• Gabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs)… recall
  FDA October 29, 2025 · The Harvard Drug Group LLC · Class II
• Gabapentin Capsules, USP, 100 mg, 10 capsules (10x1) per bag, Rx only… recall
  FDA July 9, 2025 · The Harvard Drug Group LLC · Class II
• Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10)… recall
  FDA July 9, 2025 · The Harvard Drug Group LLC · Class II